| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |